Resistance of Cancer Cells to CTL-Mediated Immunotherapy

Nonfiction, Health & Well Being, Medical, Specialties, Oncology, Medical Science, Pharmacology
Cover of the book Resistance of Cancer Cells to CTL-Mediated Immunotherapy by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319178073
Publisher: Springer International Publishing Publication: June 20, 2015
Imprint: Springer Language: English
Author:
ISBN: 9783319178073
Publisher: Springer International Publishing
Publication: June 20, 2015
Imprint: Springer
Language: English

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

More books from Springer International Publishing

Cover of the book A Readable Introduction to Real Mathematics by
Cover of the book Explorations into Chinese as a Second Language by
Cover of the book The Immunology of Cardiovascular Homeostasis and Pathology by
Cover of the book Radiation Therapy for Gastrointestinal Cancers by
Cover of the book Statistics for Mathematicians by
Cover of the book Cellular Automata by
Cover of the book Handbook of Consultation-Liaison Psychiatry by
Cover of the book Landscape and Ecosystem Diversity, Dynamics and Management in the Yellow River Source Zone by
Cover of the book Geomorphology and Physical Oceanography of the Lakshadweep Coral Islands in the Indian Ocean by
Cover of the book Entrepreneurial Finance for MSMEs by
Cover of the book Aeroecology by
Cover of the book Impact of Culture on Management of Foreign SMEs in China by
Cover of the book Counter-terrorism and the Prospects of Human Rights by
Cover of the book Correlated Functional Oxides by
Cover of the book High Performance Soft Magnetic Materials by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy